These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 4179884)
21. Therapeutic defibrination by ancrod (Arvin). Reid HA Folia Haematol Int Mag Klin Morphol Blutforsch; 1971; 95(2):209-15. PubMed ID: 4106010 [No Abstract] [Full Text] [Related]
22. Thrombosis prevention by coagulation and platelet aggregtion inhibitors, in hyperlipemic rats. Renaud S; Lecompte F Thromb Diath Haemorrh; 1970 Dec; 24(3):577-86. PubMed ID: 5503948 [No Abstract] [Full Text] [Related]
23. Effects of Ancrod (Arvin) in mice: studies of plasma fibrinogen and fibrinolytic activity. Silberman S; Bernik MB; Potter EV; Kwaan HC Br J Haematol; 1973 Jan; 24(1):101-13. PubMed ID: 4197581 [No Abstract] [Full Text] [Related]
24. Effect of purified Vipera palestinae hemorrhagin on blood coagulation and platelet function. Grotto L; Jerushalmy Z; De Vries A Thromb Diath Haemorrh; 1969 Dec; 22(3):482-95. PubMed ID: 5382286 [No Abstract] [Full Text] [Related]
25. [The blood platelets in thrombogenesis. The mechanism and inhibition of the aggregation of blood platelets]. Born GV Actual Pharmacol (Paris); 1965; 18():17-32. PubMed ID: 5874959 [No Abstract] [Full Text] [Related]
26. The effect of Arvin on experimental immune arthritis in rabbits. Ford PM; Bell WR; Bluestone R; Gumpel JM; Webb FW Br J Exp Pathol; 1970 Feb; 51(1):81-6. PubMed ID: 5434447 [TBL] [Abstract][Full Text] [Related]
27. Ancrod in sickle-cell crisis. Mann JR; Deeble TJ; Breeze GR; Stuart J Lancet; 1972 Apr; 1(7757):934-7. PubMed ID: 4112100 [No Abstract] [Full Text] [Related]
28. Platelets and thrombosis. Scott Med J; 1968 Dec; 13(12):430-3. PubMed ID: 4883725 [No Abstract] [Full Text] [Related]
29. Immunologic study of fibrinogen and its split products in venous thrombosis. Sova J Acta Univ Carol Med Monogr; 1972; 52():173-9. PubMed ID: 4593289 [No Abstract] [Full Text] [Related]
30. Treatment of deep vein thrombosis. Kakkar VV Proc R Soc Med; 1970 Feb; 63(2):133-5. PubMed ID: 5444043 [No Abstract] [Full Text] [Related]
31. A new approach to anticoagulant therapy. Lancet; 1968 Mar; 1(7541):513. PubMed ID: 4170837 [No Abstract] [Full Text] [Related]
32. Maintenance dose of Arvin. Reid HA Lancet; 1969 May; 1(7604):1048-9. PubMed ID: 4181271 [No Abstract] [Full Text] [Related]
33. A novel anticoagulant from viper venom. Lond Clin Med J; 1968 Jul; 9(2):5-6. PubMed ID: 5691042 [No Abstract] [Full Text] [Related]
34. Interaction of Arvin with erythrocyte flexibility. Myers P; Rampling MW; Sirs JA J Physiol; 1973 Apr; 230(1):51P-52P. PubMed ID: 4702445 [No Abstract] [Full Text] [Related]
35. Platelet survival and adhesiveness in recurrent venous thrombosis. Steele PP; Weily HS; Genton E N Engl J Med; 1973 May; 288(22):1148-52. PubMed ID: 4699744 [No Abstract] [Full Text] [Related]
38. Influence of Arwin on the flow properties of blood. Ehrly AM Biorheology; 1973 Sep; 10(3):453-6. PubMed ID: 4772016 [No Abstract] [Full Text] [Related]
39. [Clinical and biological significance of the phenomenon of platelet adhesiveness and aggregation]. Gavrilescu S; Bartl F; Pop T Med Interna (Bucur); 1969 Dec; 21(12):1411-30. PubMed ID: 4985383 [No Abstract] [Full Text] [Related]
40. [Effects of phentolamine on platelet aggregation]. Bologna E Boll Soc Ital Biol Sper; 1969 Aug; 45(15):1033-5. PubMed ID: 5374898 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]